Veterinary Medicines

Rapidexon 2 mg/ml Solution injectable

Authorised
  • Dexamethasone sodium phosphate
Download as PDF

Product identification

Medicine name:
Rapidexon 2 mg/ml Solution injectable
Rapidexon 2 mg/ml Injektionslösung
Active substance:
  • Dexamethasone sodium phosphate
Target species:
  • Cattle
  • Pig
  • Horse
  • Dog
  • Cat
Route of administration:
  • Intraarterial use
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Dexamethasone sodium phosphate
    2.63
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intraarterial use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        2
        day
    • Horse
      • Meat and offal
        8
        day
    • Dog
    • Cat
  • Intramuscular use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        2
        day
    • Horse
      • Meat and offal
        8
        day
    • Dog
    • Cat
  • Intravenous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        2
        day
    • Horse
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • 100 ml vial glass type I uncoloured with bromobutyl rubber stopper type I secured with aluminium cap
  • 25 ml vial glass type I uncoloured with bromobutyl rubber stopper type I secured with aluminium cap
  • 50 ml vial glass type I uncoloured with bromobutyl rubber stopper type I secured with aluminium cap

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 914/98/02/0586
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."